ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,401, issued on May 27, was assigned to iTeos Belguim SA (Gosselies, Belgium).
"Anti-TIGIT antibodies" was invented by Catherine Hoofd (Chastre-Villeroux-Blanmont, Belgium), Gregory Driessens (Ottignies, Belgium) and Julia Cuende (Bertem, Belgium).
According to the abstract* released by the U.S. Patent & Trademark Office: "Anti-TIGIT antibodies and antigen binding fragments that inhibit TIGIT-mediated signaling, plus related details, are provided on consultation of the full patent text. Combinations of these anti-TIGIT antibodies and antigen binding fragments with additional therapeutic agents, plus related details, are also provided on consultation of the full patent text. Method...